Contact
searchSearch
HMP Global

Hidradenitis Suppurativa Topic Center

Featured

Face
FDA Alerts
Bimekizumab FDA Approved for Moderate to Severe Hidradenitis Suppurativa
11/20/2024
Riya Gandhi, MA
The US Food and Drug Administration has approved UCB’s BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa.
The US Food and Drug Administration has approved UCB’s BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa.
The US Food and Drug...
11/20/2024
The Dermatologist
Hidradenitis Suppurativa
News
Evolving Treatment Paradigms for Hidradenitis Suppurativa: The Role of Biologics
10/31/2024
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS...
10/31/2024
The Dermatologist
FDA Alerts
Secukinumab Approved as New Biologic Treatment Option for Hidradenitis Suppurativa
11/01/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug...
11/01/2023
The Dermatologist
News
Intramuscular Triamcinolone Therapy for Acute Flares of Hidradenitis Suppurativa
07/18/2023
Jessica Garlewicz
Researchers aimed to conduct a retrospective analysis and patient surveys to investigate the efficacy and patient experience of intramuscular triamcinolone therapy for acute, severe hidradenitis suppurativa flares.
Researchers aimed to conduct a retrospective analysis and patient surveys to investigate the efficacy and patient experience of intramuscular triamcinolone therapy for acute, severe hidradenitis suppurativa flares.
Researchers aimed to conduct a...
07/18/2023
The Dermatologist
News
Smoking and Obesity Are Important Research Questions for Managing Hidradenitis Suppurativa
04/10/2023
Lisa Kuhns, PhD, MD
An expert consensus of priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa (HS) was developed in a recent Delphi consensus study.
An expert consensus of priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa (HS) was developed in a recent Delphi consensus study.
An expert consensus of priority...
04/10/2023
The Dermatologist
News
Complete Remission of Hidradenitis Suppurativa Reported After Treatment With Thoracodorsal Artery Perforator Flap
04/05/2023
Lisa Kuhns, PhD, MD
Thoracodorsal artery perforator (TDAP) flap-based reconstruction following wide local excision (WLE) resulted in the complete remission of hidradenitis suppurativa (HS), according to a recent study published in Plastic and Reconstructive...
Thoracodorsal artery perforator (TDAP) flap-based reconstruction following wide local excision (WLE) resulted in the complete remission of hidradenitis suppurativa (HS), according to a recent study published in Plastic and Reconstructive...
Thoracodorsal artery perforator...
04/05/2023
The Dermatologist
News
Effectiveness and Pain Reduction Identified as the Most Important Treatment Attributes in Hidradenitis Suppurativa Management
01/31/2023
Lisa Kuhns, PhD, MD
In a multinational discrete choice experiment, researchers aimed to determine which treatment attributes adult patients with HS in Europe consider the most important in treatment decision-making.
In a multinational discrete choice experiment, researchers aimed to determine which treatment attributes adult patients with HS in Europe consider the most important in treatment decision-making.
In a multinational discrete...
01/31/2023
The Dermatologist
News
Hidradenitis Suppurativa Contributes to Relationship Disturbances
12/08/2022
Lisa Kuhns, PhD, MD
Researchers aimed to determine relationship disturbances in HS using an anonymous electronic survey.
Researchers aimed to determine relationship disturbances in HS using an anonymous electronic survey.
Researchers aimed to determine...
12/08/2022
The Dermatologist
News
Pediatric Hidradenitis Suppurativa Presents Similar Clinical Spectrum to Adult-Onset Disease
11/30/2022
Lisa Kuhns, PhD, MD
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a...
11/30/2022
The Dermatologist
News
Stigmatization Has a Debilitating Impact on Patients With Hidradenitis Suppurativa
11/18/2022
Lisa Kuhns, PhD, MD
Researchers performed an observational study that aimed to assess how feelings of stigmatization may relate to patient quality of life, depression, and social anxiety.
Researchers performed an observational study that aimed to assess how feelings of stigmatization may relate to patient quality of life, depression, and social anxiety.
Researchers performed an...
11/18/2022
The Dermatologist
News
Increased Epigenetic Age May Be a Biomarker of Disease Burden in Hidradenitis Suppurativa
11/09/2022
Lisa Kuhns, PhD, MD
Researchers performed a pilot study to calculate EAA in the skin of patients with hidradenitis suppurativa.
Researchers performed a pilot study to calculate EAA in the skin of patients with hidradenitis suppurativa.
Researchers performed a pilot...
11/09/2022
The Dermatologist

Q&As

Dr Amit Garg: Comorbidity Screening in HS
Q&As
Dr Amit Garg: Comorbidity Screening in HS
05/19/2021
Amit Garg, MD, shares insights into Hidradenitis Suppurativa and discusses his latest study, “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations”.
Amit Garg, MD, shares insights into Hidradenitis Suppurativa and discusses his latest study, “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations”.
Amit Garg, MD, shares insights...
05/19/2021
The Dermatologist
Dr Haley Naik on Hidradenitis Suppurativa: Current Medical and Surgical Management
Q&As
Dr Haley Naik on Hidradenitis Suppurativa: Current Medical and Surgical Management
04/24/2021
Dr Haley Naik, MD, MHSc, FAAD joined The Dermatologist prior to her session at AAD VMX 2021 to discuss the current medical and surgical management options for hidradenitis suppurativa.
Dr Haley Naik, MD, MHSc, FAAD joined The Dermatologist prior to her session at AAD VMX 2021 to discuss the current medical and surgical management options for hidradenitis suppurativa.
Dr Haley Naik, MD, MHSc, FAAD...
04/24/2021
The Dermatologist
The Who and When of Intralesional Injections for HS Treatment
Q&As
The Who and When of Intralesional Injections for HS Treatment
03/26/2021
Steven R. Cohen, MD, MPH, met with The Dermatologist to discuss the efficacy of high dose intralesional triamcinolone (ILTAC) for hidradenitis suppurativa.
Steven R. Cohen, MD, MPH, met with The Dermatologist to discuss the efficacy of high dose intralesional triamcinolone (ILTAC) for hidradenitis suppurativa.
Steven R. Cohen, MD, MPH, met...
03/26/2021
The Dermatologist
Brandon Adler, MD
Q&As
Insights Into Photoprotection Updates
02/08/2024
Jessica Garlewicz
Dr Brandon Adler shared the latest updates in sunscreen usage, and how physicians can implement these changes in their practices.
Dr Brandon Adler shared the latest updates in sunscreen usage, and how physicians can implement these changes in their practices.
Dr Brandon Adler shared the...
02/08/2024
The Dermatologist
Glynis Ablon
Q&As
Enhancing Appearance Procedures
02/04/2024
Riya Gandhi, MA
In this interview, Dr Ablon explored cutting-edge techniques, personalized approaches, and practical insights in appearance procedures by addressing complications, patient satisfaction, and guidance for dermatologists.
In this interview, Dr Ablon explored cutting-edge techniques, personalized approaches, and practical insights in appearance procedures by addressing complications, patient satisfaction, and guidance for dermatologists.
In this interview, Dr Ablon...
02/04/2024
The Dermatologist
Jonathan Silverberg, MD, PhD, MPH
Q&As
Revolutionizing Atopic Dermatitis: Virtual Sessions on Optimizing Patient Care
12/13/2023
Jessica Garlewicz
Dr Jonathan Silverberg discussed how he hoped physicians gained a better understanding of the latest research and approaches when treating atopic dermatitis during the Revolutionizing Atopic Dermatitis virtual session.
Dr Jonathan Silverberg discussed how he hoped physicians gained a better understanding of the latest research and approaches when treating atopic dermatitis during the Revolutionizing Atopic Dermatitis virtual session.
Dr Jonathan Silverberg discussed...
12/13/2023
The Dermatologist
Elliott Campbell
Q&As
Gender Disparities and Advances in Cutaneous Melanoma
11/01/2023
Elliott Campbell, MD, FAAD
In this interview, Dr Elliott Campbell explores the increasing melanoma incidence among middle-aged women alongside stable rates in middle-aged men.
In this interview, Dr Elliott Campbell explores the increasing melanoma incidence among middle-aged women alongside stable rates in middle-aged men.
In this interview, Dr Elliott...
11/01/2023
The Dermatologist
Ilka A. Netravali, MD, PhD, FAAD
Q&As
Rapid Resolution of Diffuse Warts Following Initiation of Dupilumab for Severe Atopic Dermatitis
10/30/2023
Ilka Arun Netravali, MD, PhD, FAAD
Dr Ilka Netravali shared insights from her study, “Rapid Resolution of Diffuse Warts Following Initiation of Dupilumab for Severe Atopic Dermatitis.”
Dr Ilka Netravali shared insights from her study, “Rapid Resolution of Diffuse Warts Following Initiation of Dupilumab for Severe Atopic Dermatitis.”
Dr Ilka Netravali shared...
10/30/2023
The Dermatologist
Jeremy Etzkorn-2019
Q&As
Nasal Function and Appearance Post Flap Repair: NAFEQ Study
09/26/2023
Jeremy Etzkorn, MD; Nicholas J. Golda, MD
In this interview, Dr Etzkorn and Dr Golda discussed the findings of their multi-center prospective cohort study on patients undergoing 2-stage interpolated flap repair for nasal defects.
In this interview, Dr Etzkorn and Dr Golda discussed the findings of their multi-center prospective cohort study on patients undergoing 2-stage interpolated flap repair for nasal defects.
In this interview, Dr Etzkorn...
09/26/2023
The Dermatologist
Steven Feldman
Q&As
Advancing Psoriasis Patient Care
09/25/2023
Steven R. Feldman, MD, PhD
In this interview with The Dermatologist, Dr Steven Feldman discusses his session, “Better Care for Psoriasis Patients,” presented at Fall Dermatology Week 2023.
In this interview with The Dermatologist, Dr Steven Feldman discusses his session, “Better Care for Psoriasis Patients,” presented at Fall Dermatology Week 2023.
In this interview with The...
09/25/2023
The Dermatologist
Derek Chu, MD, PhD, FRCPC
Q&As
Systemic and Topical Treatments For Atopic Dermatitis
09/20/2023
Jessica Garlewicz
In this feature interview with The Dermatologist, Dr Derek Chu discusses systemic treatments for atopic dermatitis and also how physicians can consider the benefits and harms of prescription topical treatments.
In this feature interview with The Dermatologist, Dr Derek Chu discusses systemic treatments for atopic dermatitis and also how physicians can consider the benefits and harms of prescription topical treatments.
In this feature interview with...
09/20/2023
The Dermatologist
Emily Ruiz, MD, MPH
Q&As
Nonsurgical Approaches for Skin Cancer
09/12/2023
Emily Ruiz, MD, MPH
In this interview, Dr Emily Ruiz offers a glimpse into her upcoming session, “Nonsurgical Treatments for Skin Cancer,” at Dermatology Week Fall 2023.
In this interview, Dr Emily Ruiz offers a glimpse into her upcoming session, “Nonsurgical Treatments for Skin Cancer,” at Dermatology Week Fall 2023.
In this interview, Dr Emily Ruiz...
09/12/2023
The Dermatologist
Walayat Hussain, BSc, MBChB, MRCP, FRACP, FACMS
Q&As
Global Insights into Mohs Practice and Facial Reconstruction
09/06/2023
Walayat Hussain, BSc, MBChB, MRCP, FRACP, FACMS
In this engaging interview, Dr Hussain discusses international variations in Mohs practice and shares insights from his session, “International Perspectives on Mohs & Facial Reconstruction,” presented at the 2023 American College of Mohs...
In this engaging interview, Dr Hussain discusses international variations in Mohs practice and shares insights from his session, “International Perspectives on Mohs & Facial Reconstruction,” presented at the 2023 American College of Mohs...
In this engaging interview, Dr...
09/06/2023
The Dermatologist

Multimedia

Dr Sherry Yang
Videos
Inflammation's Role in the Disease Progression of HS
11/17/2021
Sherry Yang, MD, FAAD
Dr Sherry Yang discusses the various causes of inflammation and their role in the disease progression of patients with HS.
Dr Sherry Yang discusses the various causes of inflammation and their role in the disease progression of patients with HS.
Dr Sherry Yang discusses the...
11/17/2021
The Dermatologist
Dr Sherry Yang
Videos
Demographics & Characteristics Associated With HS Diagnoses
11/12/2021
Sherry Yang, MD, FAAD
Dr Sherry Yang discusses patient demographics and characteristics that are associated with HS diagnoses.
Dr Sherry Yang discusses patient demographics and characteristics that are associated with HS diagnoses.
Dr Sherry Yang discusses patient...
11/12/2021
The Dermatologist
Dr Sherry Yang
Videos
How to Approach HS Treatment
11/05/2021
Sherry Yang, MD, FAAD
Dr Sherry Yang discusses how individualizing treatment plans for each patient is one of the best approaches to combatting HS symptoms.
Dr Sherry Yang discusses how individualizing treatment plans for each patient is one of the best approaches to combatting HS symptoms.
Dr Sherry Yang discusses how...
11/05/2021
The Dermatologist
Videos
Clinical Implications of HS and Hepatitis B/C
06/10/2021
Dr Cohen shares the clinical implications of hepatitis B and hepatitis C in patients with HS in this 8-minute video.
Dr Cohen shares the clinical implications of hepatitis B and hepatitis C in patients with HS in this 8-minute video.
Dr Cohen shares the clinical...
06/10/2021
The Dermatologist
Videos
Genetic Components and Hepatitis Risks in HS
06/10/2021
In this video interview, Dr Cohen highlights results of his recent study into HS and hepatitis B and C.
In this video interview, Dr Cohen highlights results of his recent study into HS and hepatitis B and C.
In this video interview, Dr...
06/10/2021
The Dermatologist
Podcasts
Updates in HS: Dr Rosenblum on Pathophysiology
12/15/2020
In this podcast, Michael Rosenblum, MD, reviews the pathophysiology of hidradenitis suppurativa and a possible immune activation signature that could potentially identify patients who may respond to TNF therapies.
In this podcast, Michael Rosenblum, MD, reviews the pathophysiology of hidradenitis suppurativa and a possible immune activation signature that could potentially identify patients who may respond to TNF therapies.
In this podcast, Michael...
12/15/2020
The Dermatologist
Podcasts
Dr Iltefat Hamzavi on Managing Hidradenitis Suppurativa
09/16/2020
In this podcast, Iltefat Hamzavi, MD, discusses therapeutic options for managing flares, the role of lasers, and new therapies in the pipeline for hidradenitis suppurativa.
In this podcast, Iltefat Hamzavi, MD, discusses therapeutic options for managing flares, the role of lasers, and new therapies in the pipeline for hidradenitis suppurativa.
In this podcast, Iltefat...
09/16/2020
The Dermatologist
Dr Maryanne Senna
NAAF-Reviewed Content
The Reality of Alopecia Areata: Dispelling Myths and Raising Awareness, Part 1
04/21/2025
Maryanne Makredes Senna, MD
Maryanne Makredes Senna, MD, introduces the clinical fundamentals of alopecia areata, including its immunologic underpinnings, diagnostic challenges, and association with other medical conditions. Dr Senna demystifies the disease’s...
Maryanne Makredes Senna, MD, introduces the clinical fundamentals of alopecia areata, including its immunologic underpinnings, diagnostic challenges, and association with other medical conditions. Dr Senna demystifies the disease’s...
Maryanne Makredes Senna, MD,...
04/21/2025
The Dermatologist
Dr Victoria Barbosa
NAAF-Reviewed Content
The Role of Patient-Centered Communication in Alopecia Areata Treatment, Part 1
04/17/2025
In this first episode of a two-part podcast, Victoria Barbosa, MD, introduces the foundational principles of patient-centered communication in the context of alopecia areata. She reflects on why many patients seek second or third opinions and...
In this first episode of a two-part podcast, Victoria Barbosa, MD, introduces the foundational principles of patient-centered communication in the context of alopecia areata. She reflects on why many patients seek second or third opinions and...
In this first episode of a...
04/17/2025
The Dermatologist
Videos
Operational and Logistical Considerations With IO Therapy for Advanced Non-Melanoma Skin Cancer
04/11/2025
In this final roundtable discussion, speakers discuss the operational and logistical aspects of delivering immuno-oncology (IO) therapy for patients with advanced basal cell carcinoma and advanced cutaneous squamous cell carcinoma.
In this final roundtable discussion, speakers discuss the operational and logistical aspects of delivering immuno-oncology (IO) therapy for patients with advanced basal cell carcinoma and advanced cutaneous squamous cell carcinoma.
In this final roundtable...
04/11/2025
The Dermatologist
Videos
Real-World Case Studies and Insights on IO Therapy for Advanced Non-Melanoma Skin Cancer
04/11/2025
This video presents real-world patient cases from each of the three expert speakers, illustrating the practical use of immuno-oncology (IO) therapy in treating advanced basal cell carcinoma and advanced cutaneous squamous cell carcinoma.
This video presents real-world patient cases from each of the three expert speakers, illustrating the practical use of immuno-oncology (IO) therapy in treating advanced basal cell carcinoma and advanced cutaneous squamous cell carcinoma.
This video presents real-world...
04/11/2025
The Dermatologist
Brittany Gareth Craiglow, MD, FAAD
Videos
Alopecia Areata in Children
04/11/2025
Brittany Craiglow, MD
Explore expert insights on pediatric alopecia areata, including differences in presentation and treatment vs. adults, diagnostic strategies, quality of life considerations, and tailored management approaches to support young patients and...
Explore expert insights on pediatric alopecia areata, including differences in presentation and treatment vs. adults, diagnostic strategies, quality of life considerations, and tailored management approaches to support young patients and...
Explore expert insights on...
04/11/2025
The Dermatologist
Videos
Identifying The Appropriate Patient for IO Therapy in Advanced Non-Melanoma Skin Cancer
04/11/2025
In this segment, expert faculty explore the clinical considerations involved in selecting patients with aBCC and aCSCC for immuno-oncology (IO) therapy. Topics include evaluation criteria, comorbidities, patient characteristics, and the...
In this segment, expert faculty explore the clinical considerations involved in selecting patients with aBCC and aCSCC for immuno-oncology (IO) therapy. Topics include evaluation criteria, comorbidities, patient characteristics, and the...
In this segment, expert faculty...
04/11/2025
The Dermatologist
Vishal Anil Patel, MD
Videos
AAD 2025 Recap: Advanced Skin Cancer
04/08/2025
Jessica Garlewicz
In this feature video Dr Patel discusses how immunotherapies and targeted agents are reshaping the treatment landscape for advanced skin cancer.
In this feature video Dr Patel discusses how immunotherapies and targeted agents are reshaping the treatment landscape for advanced skin cancer.
In this feature video Dr Patel...
04/08/2025
The Dermatologist
Patrick Burnett
Videos
Roflumilast Cream for Atopic Dermatitis in Pediatric Dermatology
03/13/2025
Patrick Burnett, MD, PhD, FAAD
Dr Patrick Burnett discusses the significance of roflumilast cream, a non-steroidal treatment, its rapid itch relief within 24 hours, and its role in long-term disease management.
Dr Patrick Burnett discusses the significance of roflumilast cream, a non-steroidal treatment, its rapid itch relief within 24 hours, and its role in long-term disease management.
Dr Patrick Burnett discusses the...
03/13/2025
The Dermatologist
Fabrizio Galimberti, MD
Videos
Treating Generalized Pustular Psoriasis
03/13/2025
Jessica Garlewicz
Generalized pustular psoriasis (GPP) is a rare but life-threatening condition that requires early recognition and prompt intervention.
Generalized pustular psoriasis (GPP) is a rare but life-threatening condition that requires early recognition and prompt intervention.
Generalized pustular psoriasis...
03/13/2025
The Dermatologist
Abigail H. Waldman, MD, FAAD
Videos
Non-Surgical Treatment For Skin Cancer
03/06/2025
Jessica Garlewicz
Learn how dermatologists can optimize patient outcomes while integrating emerging data into daily practice.
Learn how dermatologists can optimize patient outcomes while integrating emerging data into daily practice.
Learn how dermatologists can...
03/06/2025
The Dermatologist

Quizzes

severe hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa Risk Factor for Infection Following Procedures
07/26/2022
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following...
07/26/2022
The Dermatologist
hidradenitis suppurativa under arm
Quiz
Trivia: Internalized Skin Bias in HS
05/17/2022
Which of the following options are predictors of impaired health-related quality of life?
Which of the following options are predictors of impaired health-related quality of life?
Which of the following options...
05/17/2022
The Dermatologist
HS lesions
Quiz
Trivia: Are Female Patients With HS At High Risk for Adverse Pregnancy Outcomes?
12/21/2021
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an...
12/21/2021
The Dermatologist
HS lesions
Quiz
Trivia: How are Patients With HS and Hepatitis B or C Systemically Treated?
12/21/2021
True or false: Patients with HS who have hepatitis B or C are always given the same standard treatment.
True or false: Patients with HS who have hepatitis B or C are always given the same standard treatment.
True or false: Patients with HS...
12/21/2021
The Dermatologist
HS lesions
Quiz
Trivia: What is the Optimal Dose Regimen Recommended for HS Lesions?
12/21/2021
True or false: The use of intralesional steroids is very ineffective with traditional doses of 5 mg/mL and 10 mg/mL.
True or false: The use of intralesional steroids is very ineffective with traditional doses of 5 mg/mL and 10 mg/mL.
True or false: The use of...
12/21/2021
The Dermatologist
hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa and the Risk for Hepatitis B and C
12/20/2021
True or False: Patients with hidradenitis suppurativa are at an increased risk for hepatitis B or C.
True or False: Patients with hidradenitis suppurativa are at an increased risk for hepatitis B or C.
True or False: Patients with...
12/20/2021
The Dermatologist
hidradenitis in armpit
Quiz
Trivia: Characteristics Tied to New Hidradenitis Suppurativa Diagnoses
12/17/2021
According to Sherry Yang, MD, FAAD, which characteristics are associated with new HS diagnoses?
According to Sherry Yang, MD, FAAD, which characteristics are associated with new HS diagnoses?
According to Sherry Yang, MD,...
12/17/2021
The Dermatologist
hidradenitis
Quiz
Trivia: Risk for Therapy Discontinuation Among Patients With HS
12/10/2021
True or False: In a study of patients with hidradenitis suppurativa, the risk for discontinuation of was significantly lower among those given etanercept vs adalimumab, infliximab, and ustekinumab.
True or False: In a study of patients with hidradenitis suppurativa, the risk for discontinuation of was significantly lower among those given etanercept vs adalimumab, infliximab, and ustekinumab.
True or False: In a study of...
12/10/2021
The Dermatologist
hidradenitis tunneling
Quiz
Trivia: Ranking of Monotherapies for Hidradenitis Suppurativa
12/03/2021
Test your knowledge of the efficacy of single-agent therapies for patients with HS.
Test your knowledge of the efficacy of single-agent therapies for patients with HS.
Test your knowledge of the...
12/03/2021
The Dermatologist
Hidradenitis Suppurativa, as shown here, is a terrible condition that can affect pediatric patients and their HS treatment.
Quiz
Trivia: Physical and Psychosocial Comorbidities in Pediatric HS
09/28/2021
Can you identify which of these options lists some of the comorbidities associated with pediatric with HS?
Can you identify which of these options lists some of the comorbidities associated with pediatric with HS?
Can you identify which of these...
09/28/2021
The Dermatologist
Atopic dermatitis
Quiz
Manage Acute Flares in Atopic Dermatitis
04/22/2025
Riya Gandhi, MA
Test your knowledge on managing acute flares in atopic dermatitis. Learn about eczema action plans, proactive care models, and key patient education strategies to improve outcomes.
Test your knowledge on managing acute flares in atopic dermatitis. Learn about eczema action plans, proactive care models, and key patient education strategies to improve outcomes.
Test your knowledge on managing...
04/22/2025
The Dermatologist
telemedicine
Quiz
Patient-Provider Alignment on AD Flare
03/25/2025
Riya Gandhi, MA
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and...
03/25/2025
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/20/2025
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/20/2025
The Dermatologist
Atopic Dermatitis + Eczema_2.jpg
Quiz
Key Parts of The Flare Experience
03/16/2025
Riya Gandhi, MA
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the...
03/16/2025
The Dermatologist
Atopic dermatitis
Quiz
Indicators of an AD Flare
03/11/2025
Riya Gandhi, MA
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how...
03/11/2025
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/04/2025
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/04/2025
The Dermatologist
Atopic dermatitis
Quiz
Distinguishing Erythema Multiforme from EM-Like Reactions
02/26/2025
Riya Gandhi, MA
Test your dermatology knowledge and dive into the EM-like reactions vs. EM. Ready to boost your clinical pearls? Check out the quiz now!
Test your dermatology knowledge and dive into the EM-like reactions vs. EM. Ready to boost your clinical pearls? Check out the quiz now!
Test your dermatology knowledge...
02/26/2025
The Dermatologist
Puzzle pieces with words Alopecia Areata
Quiz
Test Your Knowledge: Diagnosing Alopecia Areata
01/24/2025
01/24/2025
The Dermatologist
Atopic Dermatitis + Eczema + Itch + Rash + Legs + Elbow + Knee
Quiz
Atopic Dermatitis and JAK Inhibitors
12/14/2024
Riya Gandhi, MA
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ...
12/14/2024
The Dermatologist
Illustration of JAK1 Protein
Quiz
Test Your Knowledge: The Immunology of JAK Inhibitors
12/05/2024
12/05/2024
The Dermatologist

News

Face
FDA Alerts
Bimekizumab FDA Approved for Moderate to Severe Hidradenitis Suppurativa
11/20/2024
Riya Gandhi, MA
The US Food and Drug Administration has approved UCB’s BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa.
The US Food and Drug Administration has approved UCB’s BIMZELX (bimekizumab-bkzx) for the treatment of adults with moderate to severe hidradenitis suppurativa.
The US Food and Drug...
11/20/2024
The Dermatologist
Hidradenitis Suppurativa
News
Evolving Treatment Paradigms for Hidradenitis Suppurativa: The Role of Biologics
10/31/2024
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS...
10/31/2024
The Dermatologist
FDA Alerts
Secukinumab Approved as New Biologic Treatment Option for Hidradenitis Suppurativa
11/01/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug Administration recently announced approval of Cosentyx (secukinumab) for the treatment of hidradenitis suppurativa.
The US Food and Drug...
11/01/2023
The Dermatologist
News
Intramuscular Triamcinolone Therapy for Acute Flares of Hidradenitis Suppurativa
07/18/2023
Jessica Garlewicz
Researchers aimed to conduct a retrospective analysis and patient surveys to investigate the efficacy and patient experience of intramuscular triamcinolone therapy for acute, severe hidradenitis suppurativa flares.
Researchers aimed to conduct a retrospective analysis and patient surveys to investigate the efficacy and patient experience of intramuscular triamcinolone therapy for acute, severe hidradenitis suppurativa flares.
Researchers aimed to conduct a...
07/18/2023
The Dermatologist
News
Smoking and Obesity Are Important Research Questions for Managing Hidradenitis Suppurativa
04/10/2023
Lisa Kuhns, PhD, MD
An expert consensus of priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa (HS) was developed in a recent Delphi consensus study.
An expert consensus of priority research gaps in dietary and lifestyle factors in hidradenitis suppurativa (HS) was developed in a recent Delphi consensus study.
An expert consensus of priority...
04/10/2023
The Dermatologist
News
Complete Remission of Hidradenitis Suppurativa Reported After Treatment With Thoracodorsal Artery Perforator Flap
04/05/2023
Lisa Kuhns, PhD, MD
Thoracodorsal artery perforator (TDAP) flap-based reconstruction following wide local excision (WLE) resulted in the complete remission of hidradenitis suppurativa (HS), according to a recent study published in Plastic and Reconstructive...
Thoracodorsal artery perforator (TDAP) flap-based reconstruction following wide local excision (WLE) resulted in the complete remission of hidradenitis suppurativa (HS), according to a recent study published in Plastic and Reconstructive...
Thoracodorsal artery perforator...
04/05/2023
The Dermatologist
News
Effectiveness and Pain Reduction Identified as the Most Important Treatment Attributes in Hidradenitis Suppurativa Management
01/31/2023
Lisa Kuhns, PhD, MD
In a multinational discrete choice experiment, researchers aimed to determine which treatment attributes adult patients with HS in Europe consider the most important in treatment decision-making.
In a multinational discrete choice experiment, researchers aimed to determine which treatment attributes adult patients with HS in Europe consider the most important in treatment decision-making.
In a multinational discrete...
01/31/2023
The Dermatologist
News
Hidradenitis Suppurativa Contributes to Relationship Disturbances
12/08/2022
Lisa Kuhns, PhD, MD
Researchers aimed to determine relationship disturbances in HS using an anonymous electronic survey.
Researchers aimed to determine relationship disturbances in HS using an anonymous electronic survey.
Researchers aimed to determine...
12/08/2022
The Dermatologist
News
Pediatric Hidradenitis Suppurativa Presents Similar Clinical Spectrum to Adult-Onset Disease
11/30/2022
Lisa Kuhns, PhD, MD
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a cross-sectional study on the clinical features and treatment approaches of pediatric HS.
Researchers performed a...
11/30/2022
The Dermatologist
News
Stigmatization Has a Debilitating Impact on Patients With Hidradenitis Suppurativa
11/18/2022
Lisa Kuhns, PhD, MD
Researchers performed an observational study that aimed to assess how feelings of stigmatization may relate to patient quality of life, depression, and social anxiety.
Researchers performed an observational study that aimed to assess how feelings of stigmatization may relate to patient quality of life, depression, and social anxiety.
Researchers performed an...
11/18/2022
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Dupilumab (Dupixent) for Chronic Spontaneous Urticaria in Patients Aged 12 and Older
04/22/2025
Jessica Garlewicz
The US Food and Drug Administration (FDA) approved dupilumab for the treatment of chronic spontaneous urticaria in adults and adolescents aged 12 years and older.
The US Food and Drug Administration (FDA) approved dupilumab for the treatment of chronic spontaneous urticaria in adults and adolescents aged 12 years and older.
The US Food and Drug...
04/22/2025
The Dermatologist
psoriatic arthritis
News
Updated Evidence Reinforces Efficacy and Safety of Pharmacologic Therapies in Psoriatic Arthritis
04/17/2025
Jessica Garlewicz
A new systematic literature review provides an updated overview of the efficacy and safety of pharmacologic treatments for psoriatic arthritis.
A new systematic literature review provides an updated overview of the efficacy and safety of pharmacologic treatments for psoriatic arthritis.
A new systematic literature...
04/17/2025
The Dermatologist
psoriasis
News
Study Identifies Unidirectional Link Between Primary Biliary Cirrhosis and Psoriasis Risk
04/17/2025
Jessica Garlewicz
Is there a causal relationship between primary biliary cirrhosis and psoriasis?
Is there a causal relationship between primary biliary cirrhosis and psoriasis?
Is there a causal relationship...
04/17/2025
The Dermatologist
psoriatic arthritis
News
New Meta-Review Highlights Prevalence and Psychological Burden of Psoriatic Arthritis
04/01/2025
Jessica Garlewicz
A new overview of systematic reviews consolidates existing data on the global prevalence, incidence, and psychological comorbidities associated with psoriatic arthritis.
A new overview of systematic reviews consolidates existing data on the global prevalence, incidence, and psychological comorbidities associated with psoriatic arthritis.
A new overview of systematic...
04/01/2025
The Dermatologist
psoriasis
News
International Consensus Defines Generalized Pustular Psoriasis for Clinical and Research Use
04/01/2025
Jessica Garlewicz
The dermatology experts effort aims to reduce diagnostic delays and improve comparability in global research on generalized pustular psoriasis, which has previously lacked universally accepted clinical parameters.
The dermatology experts effort aims to reduce diagnostic delays and improve comparability in global research on generalized pustular psoriasis, which has previously lacked universally accepted clinical parameters.
The dermatology experts effort...
04/01/2025
The Dermatologist
psoriasis
News
Expanding the Scope of Psoriatic Disease: Beyond the Skin
03/20/2025
Jessica Garlewicz
Psoriasis has traditionally been viewed as a chronic inflammatory disease confined to the skin. However, growing evidence from dermatologic, rheumatologic, and cardiologic research supports its classification as a systemic disease.
Psoriasis has traditionally been viewed as a chronic inflammatory disease confined to the skin. However, growing evidence from dermatologic, rheumatologic, and cardiologic research supports its classification as a systemic disease.
Psoriasis has traditionally been...
03/20/2025
The Dermatologist
psoriasis
News
Risk of Psoriatic Arthritis Development in Patients with Subclinical PsA
03/19/2025
Jessica Garlewicz
The study followed 384 patients with psoriasis for an average of 33 months, with 311 (80.9%) classified as having subclinical psoriatic arthritis.
The study followed 384 patients with psoriasis for an average of 33 months, with 311 (80.9%) classified as having subclinical psoriatic arthritis.
The study followed 384 patients...
03/19/2025
The Dermatologist
News
Biologic Class May Influence Psoriatic Arthritis Risk in Patients With Plaque Psoriasis
03/10/2025
A retrospective observational study suggests that the risk of developing psoriatic arthritis in patients with plaque psoriasis may vary depending on the class of biologic therapy used.
A retrospective observational study suggests that the risk of developing psoriatic arthritis in patients with plaque psoriasis may vary depending on the class of biologic therapy used.
A retrospective observational...
03/10/2025
The Dermatologist
psoriatic arthritis
News
Metabolic Syndrome in Psoriatic Arthritis Linked to Degenerative Spinal and Enthesopathic Changes
03/04/2025
Jessica Garlewicz
A large observational study evaluated the relationship between metabolic syndrome and radiographic features in psoriatic arthritis.
A large observational study evaluated the relationship between metabolic syndrome and radiographic features in psoriatic arthritis.
A large observational study...
03/04/2025
The Dermatologist
psoriasis
News
Biologic Therapy in Psoriasis: No Significant Increase in Cancer Risk
03/04/2025
Jessica Garlewicz
Is there a significant increase in malignancy risk associated with biologic therapies for psoriasis?
Is there a significant increase in malignancy risk associated with biologic therapies for psoriasis?
Is there a significant increase...
03/04/2025
The Dermatologist

Popular Articles

Emily Ruiz, MD, MPH
Videos
Topical Therapy for Treating Squamous Cell Carcinoma in Situ
05/31/2023
Riya Gandhi, MA
In this interview, Dr Emily Ruiz discusses her session, “Pro and Con: Contentious Concepts,” at the 2023 ACMS Annual Meeting. She covered the topic, “Mohs vs Topical Therapy for Squamous Cell Carcinoma in Situ: Pro Topical Therapy.”
In this interview, Dr Emily Ruiz discusses her session, “Pro and Con: Contentious Concepts,” at the 2023 ACMS Annual Meeting. She covered the topic, “Mohs vs Topical Therapy for Squamous Cell Carcinoma in Situ: Pro Topical Therapy.”
In this interview, Dr Emily Ruiz...
05/31/2023
The Dermatologist
Ron Vender
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
07/13/2023
Ronald Vender, MD, FRCPC
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
07/13/2023
The Dermatologist
Case Report
An Atypical Morphology of Oral Lichen Planus
08/11/2023
Sheryl Hoyer, MD; Connor Cole, MD; Marylee Braniecki, MD
The presented case may prove to be useful for clinicians in the recognition of this lichen planus subclassification, particularly in patients with darker skin tones.
The presented case may prove to be useful for clinicians in the recognition of this lichen planus subclassification, particularly in patients with darker skin tones.
The presented case may prove to...
08/11/2023
The Dermatologist
Feature Story
3-Step Approach to Increase Diversity in Mohs Micrographic Surgery
09/11/2023
Lauren Hollins, MD; Todd Cartee, MD; Norhan Shamloul, MD
With data showing that patients with skin of color have higher morbidity and mortality from skin cancers despite lower incidence rates, it is time to reassess how our care is delivered and who is delivering that care.
With data showing that patients with skin of color have higher morbidity and mortality from skin cancers despite lower incidence rates, it is time to reassess how our care is delivered and who is delivering that care.
With data showing that patients...
09/11/2023
The Dermatologist
Joel M. Gelfand, MD, MSCE
Conference Coverage
Psoriasis and Psoriatic Arthritis: Emphasis on Comprehensive Care
09/23/2023
Jessica Garlewicz
On the final day of Fall Dermatology Week 2023, Joseph F. Merola, MD, MMSc, and Joel M. Gelfand, MD, MSCE, shared what a more comprehensive care experience means, and how physicians can build trust with their patients.
On the final day of Fall Dermatology Week 2023, Joseph F. Merola, MD, MMSc, and Joel M. Gelfand, MD, MSCE, shared what a more comprehensive care experience means, and how physicians can build trust with their patients.
On the final day of Fall...
09/23/2023
The Dermatologist

Subscribe

The Dermatologist Newsletter
cover

Current Issue

March 2025
Volume 33
Issue 2
Current Issue
Issue Archive

Latest Quizzes and Trivia

severe hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa Risk Factor for Infection Following Procedures
07/26/2022
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following...
07/26/2022
The Dermatologist
hidradenitis suppurativa under arm
Quiz
Trivia: Internalized Skin Bias in HS
05/17/2022
Which of the following options are predictors of impaired health-related quality of life?
Which of the following options are predictors of impaired health-related quality of life?
Which of the following options...
05/17/2022
The Dermatologist
HS lesions
Quiz
Trivia: Are Female Patients With HS At High Risk for Adverse Pregnancy Outcomes?
12/21/2021
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an...
12/21/2021
The Dermatologist
HS lesions
Quiz
Trivia: How are Patients With HS and Hepatitis B or C Systemically Treated?
12/21/2021
True or false: Patients with HS who have hepatitis B or C are always given the same standard treatment.
True or false: Patients with HS who have hepatitis B or C are always given the same standard treatment.
True or false: Patients with HS...
12/21/2021
The Dermatologist
HS lesions
Quiz
Trivia: What is the Optimal Dose Regimen Recommended for HS Lesions?
12/21/2021
True or false: The use of intralesional steroids is very ineffective with traditional doses of 5 mg/mL and 10 mg/mL.
True or false: The use of intralesional steroids is very ineffective with traditional doses of 5 mg/mL and 10 mg/mL.
True or false: The use of...
12/21/2021
The Dermatologist
hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa and the Risk for Hepatitis B and C
12/20/2021
True or False: Patients with hidradenitis suppurativa are at an increased risk for hepatitis B or C.
True or False: Patients with hidradenitis suppurativa are at an increased risk for hepatitis B or C.
True or False: Patients with...
12/20/2021
The Dermatologist
hidradenitis in armpit
Quiz
Trivia: Characteristics Tied to New Hidradenitis Suppurativa Diagnoses
12/17/2021
According to Sherry Yang, MD, FAAD, which characteristics are associated with new HS diagnoses?
According to Sherry Yang, MD, FAAD, which characteristics are associated with new HS diagnoses?
According to Sherry Yang, MD,...
12/17/2021
The Dermatologist
hidradenitis
Quiz
Trivia: Risk for Therapy Discontinuation Among Patients With HS
12/10/2021
True or False: In a study of patients with hidradenitis suppurativa, the risk for discontinuation of was significantly lower among those given etanercept vs adalimumab, infliximab, and ustekinumab.
True or False: In a study of patients with hidradenitis suppurativa, the risk for discontinuation of was significantly lower among those given etanercept vs adalimumab, infliximab, and ustekinumab.
True or False: In a study of...
12/10/2021
The Dermatologist
hidradenitis tunneling
Quiz
Trivia: Ranking of Monotherapies for Hidradenitis Suppurativa
12/03/2021
Test your knowledge of the efficacy of single-agent therapies for patients with HS.
Test your knowledge of the efficacy of single-agent therapies for patients with HS.
Test your knowledge of the...
12/03/2021
The Dermatologist
Hidradenitis Suppurativa, as shown here, is a terrible condition that can affect pediatric patients and their HS treatment.
Quiz
Trivia: Physical and Psychosocial Comorbidities in Pediatric HS
09/28/2021
Can you identify which of these options lists some of the comorbidities associated with pediatric with HS?
Can you identify which of these options lists some of the comorbidities associated with pediatric with HS?
Can you identify which of these...
09/28/2021
The Dermatologist
Atopic dermatitis
Quiz
Manage Acute Flares in Atopic Dermatitis
04/22/2025
Riya Gandhi, MA
Test your knowledge on managing acute flares in atopic dermatitis. Learn about eczema action plans, proactive care models, and key patient education strategies to improve outcomes.
Test your knowledge on managing acute flares in atopic dermatitis. Learn about eczema action plans, proactive care models, and key patient education strategies to improve outcomes.
Test your knowledge on managing...
04/22/2025
The Dermatologist
telemedicine
Quiz
Patient-Provider Alignment on AD Flare
03/25/2025
Riya Gandhi, MA
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and providers can align on defining atopic dermatitis (AD) flares to improve communication, treatment decisions, and shared decision-making. Take this interactive quiz to test your knowledge and learn how patient-centered...
Explore how patients and...
03/25/2025
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/20/2025
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/20/2025
The Dermatologist
Atopic Dermatitis + Eczema_2.jpg
Quiz
Key Parts of The Flare Experience
03/16/2025
Riya Gandhi, MA
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the patient perspective on atopic dermatitis flares? Take this quiz to explore key patient-described flare indicators, emotional and social impacts, and insights from NEA research.
How well do you understand the...
03/16/2025
The Dermatologist
Atopic dermatitis
Quiz
Indicators of an AD Flare
03/11/2025
Riya Gandhi, MA
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how patients with atopic dermatitis (AD) define and experience flares. This quiz highlights key indicators, patient-described attributes, and insights from the NEA’s research into AD flare triggers and symptoms.
Test your knowledge of how...
03/11/2025
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/04/2025
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/04/2025
The Dermatologist
Atopic dermatitis
Quiz
Distinguishing Erythema Multiforme from EM-Like Reactions
02/26/2025
Riya Gandhi, MA
Test your dermatology knowledge and dive into the EM-like reactions vs. EM. Ready to boost your clinical pearls? Check out the quiz now!
Test your dermatology knowledge and dive into the EM-like reactions vs. EM. Ready to boost your clinical pearls? Check out the quiz now!
Test your dermatology knowledge...
02/26/2025
The Dermatologist
Puzzle pieces with words Alopecia Areata
Quiz
Test Your Knowledge: Diagnosing Alopecia Areata
01/24/2025
01/24/2025
The Dermatologist
Atopic Dermatitis + Eczema + Itch + Rash + Legs + Elbow + Knee
Quiz
Atopic Dermatitis and JAK Inhibitors
12/14/2024
Riya Gandhi, MA
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ from traditional immunosuppressant treatments for atopic dermatitis?a) They work extracellularly, directly blocking cytokines.b) They target inflammation at the intracellular level and are more selective.c)...
1. How do JAK inhibitors differ...
12/14/2024
The Dermatologist
Illustration of JAK1 Protein
Quiz
Test Your Knowledge: The Immunology of JAK Inhibitors
12/05/2024
12/05/2024
The Dermatologist

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use